From: Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant
OAGV group
CAGV group
p-value
Complete success
4 (50.0%)
1 (8.3%)
0.035a
Qualified success
6 (75.0%)
6 (50.0%)
0.264a
Early hypertensive phase
1 (12.5%)
4 (33.3%)
0.375b